Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Neoleukin Therapeutics, Inc. (AQXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 8-K Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger, by and among Neoleukin Therapeutics, Inc., Project North Merger Sub, Inc. and Neurogene Inc",
"Form of Contingent Value Rights Agreement",
"Form of Neurogene Support Agreement",
"Form of Neoleukin Support Agreement",
"Form of Lock-Up Agreement",
"Letter Agreement, by and between Neoleukin Therapeutics, Inc. and Baker Bros. Advisors LP",
"NEUROGENE AND NEOLEUKIN ANNOUNCE DEFINITIVE MERGER AGREEMENT",
"Investor Presentation, dated July 2023"
06/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
03/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition"
11/30/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
Docs: "NEOLEUKIN THERAPEUTICS, INC. Condensed consolidated balance sheet data",
"2018 2019 2020 2021 2022 FUTURE NEOLEUKIN FOUNDED"
07/27/2022 8-K Regulation FD Disclosure  Interactive Data
Docs: "About Neoleukin Therapeutics, Inc."
05/16/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2022 8-K Quarterly results
Docs: "Neoleukin Therapeutics Announces First Quarter 2022 Financial Results and Corporate Update"
03/01/2022 8-K Quarterly results
Docs: "NEOLEUKIN THERAPEUTICS, INC. Condensed Consolidated Balance Sheet Data"
02/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/10/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "P R I O R"
11/16/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation"
11/04/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ATM Equity Offering Sales Agreement, by and between Neoleukin Therapeutics, Inc. and BofA Securities, Inc",
"Opinion of Fenwick & West LLP"
11/04/2021 8-K Quarterly results
Docs: "Neoleukin Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Update"
09/29/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
03/25/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
12/01/2020 8-K Entry into a Material Definitive Agreement
Docs: "FORM 8-K"
11/09/2020 8-K Quarterly results
Docs: "Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update -NL-201 IND submission anticipated by year end 2020- -Clinical Trial Notification application submitted in Australia-"
08/12/2020 8-K Quarterly results
08/03/2020 8-K Quarterly results
07/02/2020 8-K Quarterly results
06/01/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
05/06/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
04/13/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws",
"Amended and Restated Bylaws"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy